Deep Track Capital’s Axsome Therapeutics AXSM Stock Holding History

Deep Track Capital’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$171M	Sell	700,000 -400,000	-36%	-$86.7M	2.49%	18
2026 Q1	$186M	Sell	1,100,000 -50,000	-4%	-$8.64M	3.04%	7
2025 Q4	$210M	Buy	1,150,000 +250,000	+28%	+$34.9M	3.74%	8
2025 Q3	$109M	Buy	900,000 +98,629	+12%	+$11.1M	3.05%	14
2025 Q2	$83.7M	Buy	+801,371	New	+$84.9M	2.68%	13
2024 Q4	–	Sell	-857,219	Closed	-$77M	–	69
2024 Q3	$77M	Sell	857,219 -995,565	-54%	-$86.9M	2.44%	18
2024 Q2	$149M	Buy	1,852,784 +548,063	+42%	+$40.6M	4.45%	3
2024 Q1	$104M	Buy	1,304,721 +304,721	+30%	+$25.6M	2.98%	12
2023 Q4	$79.6M	Sell	1,000,000 -140,745	-12%	-$9.41M	2.66%	10
2023 Q3	$79.7M	Buy	1,140,745 +756,545	+197%	+$56.6M	3.08%	12
2023 Q2	$27.6M	Buy	+384,200	New	+$28.3M	1.28%	27

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Deep Track Capital's AXSM Position: Q2 2026 in Review

Deep Track Capital reduced its Axsome Therapeutics (AXSM) stake by 36% in Q2 2026, selling an estimated $86.7M and leaving 700,000 shares worth $171M. The position accounts for 2.49% of the portfolio, ranked #18.

Deep Track Capital first reported a position in AXSM in Q2 2023 and has held it in 11 quarters since. The position peaked at $210M in Q4 2025. 505 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Deep Track Capital held 700,000 shares of Axsome Therapeutics worth $171M as of Q2 2026.
Deep Track Capital sold 400,000 Axsome Therapeutics shares in Q2 2026, an estimated $86.7M.
Axsome Therapeutics made up 2.49% of Deep Track Capital's portfolio in Q2 2026, its #18 holding.
Deep Track Capital first reported a position in Axsome Therapeutics in Q2 2023 and has held it in 11 quarters since.
Deep Track Capital's Axsome Therapeutics position peaked at $210M in Q4 2025.
505 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.